Cardiovascular Profile of South African Adults with Low-Level Viremia during Antiretroviral Therapy

Chronic inflammation is an HIV infection feature, contributing to elevated risk of cardiovascular disease among people with HIV, which can be induced by viral replication. A proportion of antiretroviral therapy (ART) recipients fail to achieve viral suppression, despite not meeting criteria for trea...

Full description

Bibliographic Details
Main Authors:	Shani Botha-Le Roux, Olof Elvstam, Patrick De Boever, Nandu Goswami, Martin Magnusson, Peter M. Nilsson, Hans Strijdom, Per Björkman, Carla M. T. Fourie
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Series:	Journal of Clinical Medicine
Subjects:	biomarkers blood vessels cardiovascular disease human immunodeficiency virus viral load
Online Access:	https://www.mdpi.com/2077-0383/11/10/2812

Similar Items

Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment.
by: Olof Elvstam, et al.
Published: (2017-01-01)

Relationship between Endothelial Function, Antiretroviral Treatment and Cardiovascular Risk Factors in HIV Patients of African Descent in South Africa: A Cross-Sectional Study
by: Benedicta N. Nkeh-Chungag, et al.
Published: (2021-01-01)

In Vitro Susceptibility of HIV Isolates with High Growth Capability to Antiretroviral Drugs
by: Alfredo A. Hinay, et al.
Published: (2022-12-01)

Treatment with a fixed dose combination antiretroviral therapy drug containing tenofovir, emtricitabine and efavirenz is associated with cardioprotection in high calorie diet-induced obese rats.
by: Frans Everson, et al.
Published: (2018-01-01)

HIV and Antiretroviral Therapy Are Independently Associated with Cardiometabolic Variables and Cardiac Electrical Activity in Adults from the Western Cape Region of South Africa
by: Cassidy Williams, et al.
Published: (2021-09-01)

Vascular function and cardiovascular risk in a HIV infected and HIV free cohort of African ancestry: baseline profile, rationale and methods of the longitudinal EndoAfrica-NWU study
by: Carla M. T. Fourie, et al.
Published: (2020-07-01)

Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: A Swedish observational study.
by: Hanna Brattgård, et al.
Published: (2022-01-01)

A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4<sup>+</sup> T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients
by: Judith Grau-Expósito, et al.
Published: (2017-09-01)

Viral Load And Cd4+ among Hiv/Aids Patients Receiving Antiretroviral Therapy In Jayawijaya District, Papua Province, Indonesia
by: Mirna Widiyanti, et al.
Published: (2022-03-01)

Herpes Zoster in Persons Living with HIV-1 Infection: Viremia and Immunological Defects Are Strong Risk Factors in the Era of Combination Antiretroviral Therapy
by: Nathaniel B. Erdmann, et al.
Published: (2018-03-01)

Virologic response to antiretroviral therapy among human immunodeficiency virus-infected adults in a tertiary healthcare facility in Enugu State Nigeria
by: Izuchukwu F Obi, et al.
Published: (2022-01-01)

Adherence to Antiretroviral Therapy by Medication Possession Ratio and Virological Suppression among Adolescents and Young Adults Living with HIV in Dar es Salaam, Tanzania
by: Maryam Amour, et al.
Published: (2022-03-01)

A case of human immunodeficiency virus (HIV) infection without increase in HIV RNA level: A rare observation during the modern antiretroviral therapy era
by: Kentaro Iwata, et al.
Published: (2022-03-01)

Age-related differences in the vascular function and structure of South Africans living with HIV
by: Anisca Louwrens, et al.
Published: (2022-02-01)

Analysis of Retinal Blood Vessel Diameters in Pregnant Women Practicing Yoga: A Feasibility Study
by: Dejan Dinevski, et al.
Published: (2022-07-01)

Cumulative exposure to viremia: Methods for the implementation of standardized variables in longitudinal HIV studies
by: Benjamin W. Barrett, et al.
Published: (2023-01-01)

Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings
by: Ashwini Shete, et al.
Published: (2020-07-01)

Human immunodeficiency virus type 1: Role of proteins in the context of viral life cycle
by: Vikas Jha, et al.
Published: (2022-08-01)

Retrospective longitudinal analysis of low-level viremia among HIV-1 infected adults on antiretroviral therapy in KenyaResearch in context
by: Appolonia Aoko, et al.
Published: (2023-09-01)

Prevalence of feline viral leukemia in Moscow and the Moscow Oblast with the analysis of hematological and biochemical blood parameters
by: A. P. Zenchenkova
Published: (2021-07-01)

The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations
by: José O. Maldonado, et al.
Published: (2018-07-01)

Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé
by: Alex Durand Nka, et al.
Published: (2019-09-01)

Low Postseroconversion CD4<sup>+</sup> T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection
by: Angelica A. Palm, et al.
Published: (2019-02-01)

Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans
by: Azwidowi Lukhwareni, et al.
Published: (2020-06-01)

Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana
by: Bonolo B. Phinius, et al.
Published: (2020-11-01)

Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption
by: Matthew Pace, et al.
Published: (2022-08-01)

Soluble factors with antiviral activity: searching for new therapeutic targets to HIV-1 infection
by: Urquijo Sánchez, Susana, et al.
Published: (2015-01-01)

A two-dimensional discrete delay-differential system model of viremia
by: Joseph E. Carroll
Published: (2022-08-01)

Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center
by: Rongrong Yang, et al.
Published: (2014-11-01)

Immunity after organ transplantation
by: Swiss Medical Weekly
Published: (2006-02-01)

Rheumatic manifestations of hepatitis C virus infection are associated with autoantibodies but not viremia
by: Meng-Tzu Weng, et al.
Published: (2023-08-01)

Incidence of low-level viremia and its impact on virologic failure among people living with HIV-1 who switched to elvitegravir-based antiretroviral therapy
by: Jen-Yu Hsu, et al.
Published: (2022-06-01)

Unrecognized HIV infection in asymptomatic volunteer blood donors at district Peshawar, Khyber Pakhtunkhwa, Pakistan
by: I. Haq, et al.
Published: (2020-05-01)

Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir
by: Claudia R. Avalos, et al.
Published: (2017-09-01)

Specificity of the HIV-1 Protease on Substrates Representing the Cleavage Site in the Proximal Zinc-Finger of HIV-1 Nucleocapsid Protein
by: János András Mótyán, et al.
Published: (2021-06-01)

Effectiveness of antiretroviral therapy (haart) In hiv positive patients admitted to the treatment Program of “atencion integral ips” in the city of Cartagena. Colombia
by: Torres-Mora Gustavo, et al.
Published: (2011-06-01)

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
by: Hadega A Aamer, et al.
Published: (2020-08-01)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
by: Jana L. Jacobs, et al.
Published: (2019-10-01)

Cytomegalovirus retinitis and antiretroviral treatment: A fifteen year experience
by: Serisha Jay Narain, et al.
Published: (2022-03-01)

Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort
by: Tong Zhang, et al.
Published: (2020-02-01)